The first report of mutations came from a patient with a moderate COX deficiency (about 40% of control levels in fibroblasts) who was homozygous for a mutation leading to a T52P substitution. This evidence concerns the gene COX5A and hyperinsulinemic hypoglycemia, familial, 4.